SciSparc has entered into a securities purchase agreement with an institutional investor to raise gross cash proceeds of approximately $5.026 million through a private placement, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection with the private placement, the Company will issue an aggregate of 1,930,108 units, each unit consisting of two Pre-Funded Warrants. The Pre-Funded Warrants have an exercise price of $0.001 and a term of five years from the date of issuance. The closing of the private placement is expected to occur on or about October 13, 2023, subject to the satisfaction of certain customary closing conditions. Aegis Capital Corp. is acting as the exclusive placement agent for the private placement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SPRC:
- SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
- SciSparc granted European patent for its core technology
- SciSparc Granted European Patent for its Core Technology
- SciSparc Initiated Its Clinical Trial with SCI-210 in Pediatrics with Autism Spectrum Disorder
- SciSparc initiates SCI-120 clincal trial in pediatrics with ASD